<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">247</article-id><article-id pub-id-type="publisher-id">2008MOLVIS0211</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Association of &#x02212;31T&#x0003e;C and &#x02212;511 C&#x0003e;T polymorphisms in the interleukin 1 beta (<italic>IL1B</italic>) promoter in Korean keratoconus patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kim</surname><given-names>So-Hee</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mok</surname><given-names>Jee-Won</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Hyun-Seok</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Joo</surname><given-names>C.K.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Life Science, Catholic University of Korea, Seoul, Korea</aff><aff id="aff2"><label>2</label>Laboratory of Ophthalmology and Visual Science, Catholic University of Korea, Seoul, Korea</aff><aff id="aff3"><label>3</label>Korea Eye Tissue and Gene Bank, Catholic University of Korea, Seoul, Korea</aff><aff id="aff4"><label>4</label>Department of Ophthalmology, St. Mary&#x02019;s Hospital, Seoul, Korea</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Choun-Ki Joo, MD, Ph.D., Department of Ophthalmology and Visual Science, Catholic Research Institutes of Medical Science, Catholic University Medical College, Catholic University of Korea, 505 Banpo-dong, Seocho-ku, Seoul, 137-701, Korea; Phone: 011-82-2-590-2613; FAX: 011-82-2-533-3801; email: <email xlink:href="ckjoo@catholic.ac.kr">ckjoo@catholic.ac.kr</email></corresp></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>21</day><month>11</month><year>2008</year></pub-date><volume>14</volume><fpage>2109</fpage><lpage>2116</lpage><history><date date-type="received"><day>27</day><month>6</month><year>2008</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2008</year></date></history><permissions><copyright-year>2008</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>To investigate the genetic association between unrelated Korean keratoconus patients and interleukin 1 alpha (<italic>IL1A</italic>), interleukin 1 beta (<italic>IL1B</italic>), and IL1 receptor antagonist (<italic>IL1RN)</italic> gene polymorphisms.</p></sec><sec sec-type="methods"><title>Methods</title><p>We investigated the association between <italic>IL1A</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1800587">rs1800587</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071376">rs2071376</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17561">rs17561</ext-link>), <italic>IL1B</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143634">rs1143634</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143633">rs1143633</ext-link>), and <italic>IL1RN</italic> (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=419598">rs419598</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=423904">rs423904</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=424078">rs424078</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=315952">rs315952</ext-link>, variable number tandem repeat [VNTR]) polymorphisms in 100 unrelated Korean keratoconus patients. One hundred control individuals without any corneal disease were selected from the general population. Polymerase chain reaction (PCR) &#x02013; restriction fragment length polymorphism (RFLP) analysis and direct sequencing were used to screen for genetic variations in the <italic>IL1</italic> gene cluster. Haplotypes for the <italic>IL1</italic> gene cluster were constructed using Haploview version 4.0.</p></sec><sec><title>Results</title><p>We analyzed a total of 12 polymorphic sites in the <italic>IL1</italic> gene cluster. Among them, the &#x02212;511 (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link>) and &#x02212;31 (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link>) positions in the promoter region of <italic>IL1B</italic> were significantly different between patient and control groups. The C allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link> (&#x02212;511C&#x0003e;T, p=0.022, odds ratio of risk [OR]=1.46, 95% confidence intervals [CI] 0.94&#x0003c;2.27) and the T allele of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link> (&#x02212;31T&#x0003e;C, p=0.025, OR=1.43, 95% CI 0.92&#x0003c;2.22) were associated with a significantly increased risk of keratoconus in Korean patients. Linkage of the two alleles, &#x02212;31*C and &#x02212;511*T, was associated with an increased risk for keratoconus with OR=2.38 (p=0.012, 95% CI=1.116&#x02013;5.046). The *C/*A genotype of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071376">rs2071376</ext-link> in <italic>IL1A</italic> intron 6 was significantly different between the keratoconus patients and control subjects (p=0.034, OR=0.59, 95% CI 0.32&#x0003c;1.11). Other polymorphisms did not show an association with keratoconus risk.</p></sec><sec><title>Conclusions</title><p>This is the first report of <italic>IL1</italic> gene cluster mutation screening in Korean keratoconus patients. Significant differences in allelic frequency of <italic>IL1B</italic> between keratoconus patients and the control group suggest that <italic>IL1B</italic> polymorphisms may play a role in the susceptibility of unrelated Koreans to develop keratoconus.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Keratoconus (OMIM <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=148300">148300</ext-link>) is a bilateral, asymmetric, chronic, progressive ectasia of the cornea characterized by the steepening and distortion of the cornea, thinning of the apical cornea, and corneal scarring, which leads to progressive myopic and irregular astigmatism [<xref ref-type="bibr" rid="r1">1</xref>-<xref ref-type="bibr" rid="r3">3</xref>]. Histologically, the keratoconic cornea stroma may become less than one-quarter its normal thickness thereby leading to extensive distortion [<xref ref-type="bibr" rid="r4">4</xref>]. The pathophysiological processes underlying the keratoconic cornea have yet to be fully elucidated, although various studies have suggested that keratoconus is associated with eye rubbing in atopic patients [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r5">5</xref>], contact lens wearing [<xref ref-type="bibr" rid="r6">6</xref>], increased proteinase activity [<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r7">7</xref>], decreased levels of proteinase inhibitors [<xref ref-type="bibr" rid="r8">8</xref>-<xref ref-type="bibr" rid="r10">10</xref>], increased oxidative damage [<xref ref-type="bibr" rid="r11">11</xref>], and keratocyte apoptosis [<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref>].</p><p>Keratocyte apoptosis has been reported in 60% of keratoconic corneas and is triggered by the epithelial release of interleukin 1 (IL1), which is activated by chronic mechanical injury to the corneal epithelium [<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r14">14</xref>]. More specifically, IL1 has been implicated as a damage mediator, which is a modulator that regulates the apoptotic process [<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r16">16</xref>], in these eye rubbers. In addition, stromal thinning in keratoconus is caused by the stimulation of keratocyte apoptosis induced by IL1. For these reasons, <italic>IL1</italic> has been suggested as a candidate gene for keratoconus.</p><p>IL1 is a pleiotropic cytokine. It is involved in the inflammatory response, cell growth, and tissue repair in the cortex. The IL1 superfamily consists of three members, IL1 alpha (IL1&#x003b1;), IL1 beta (IL1&#x003b2;, predominant form) and IL1 receptor antagonist (IL1Ra), which are encoded by <italic>IL1A</italic>, <italic>IL1B</italic>, and <italic>IL1RN</italic>, respectively [<xref ref-type="bibr" rid="r17">17</xref>,<xref ref-type="bibr" rid="r18">18</xref>]. The <italic>IL1</italic> superfamily genes are located in tandem in a cluster on chromosome 2q14. This gene cluster contains several polymorphisms [<xref ref-type="bibr" rid="r19">19</xref>]. Among them, some polymorphisms are located within the regulatory regions of the genes. Their localization in regulatory regions suggests that they may modulate IL1 protein production by directly affecting transcription, leading to their association with altered levels of IL1 [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r20">20</xref>-<xref ref-type="bibr" rid="r22">22</xref>].</p><p>The goal of this study was to elucidate whether polymorphisms in <italic>IL1A</italic>, <italic>IL1B</italic>, and <italic>IL1RN</italic> are associated with keratoconus in Korean patients. We determined the genotype frequencies of 11 single nucleotide polymorphisms (SNPs), which were associated with altered levels of cytokines, and one variable number tandem repeat (VNTR) marker in the <italic>IL1</italic> gene cluster in unrelated Korean keratoconus patients. Identification of genetic factors that determine susceptibility to keratoconus in Korean patients may allow us to gain insight into the pathogenesis of keratoconus.</p></sec><sec sec-type="methods"><title>Methods</title><p>This study included 100 unrelated keratoconus patients of Korean descent with age ranging from 18 to 33 years old. All of the keratoconus patients were identified from the Korea Eye Tissue and Gene Bank related to Blindness in the Department of Ophthalmology at the Catholic University of Korea (Seoul, Korea). Appropriate informed consent was obtained from each subject, and all studies were performed according to the tenets of the Declaration of Helsinki. The patients were diagnosed with keratoconus based on the following criteria: (1) symptoms of keratoconus including the Munson sign, protrusion, Vogt&#x02019;s striae, corneal thickness, scarring, the Fleischer ring, signs of photokeratoscopy, signs of videokeratography, and refractive errors and (2) medical histories including age, sex, contact lens use, eye rubbing behavior, systemic disease, atopy, and connective tissue disease [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r23">23</xref>]. One hundred age-matched control individuals with no history of keratoconus were also enrolled from the Korea Eye Tissue and Gene Bank related to Blindness.</p><p>DNA was extracted from peripheral blood samples using the QIAamp DNA blood kit (QIAGEN, Valencia, CA). Polymerase chain reaction (PCR) reactions were performed with 25 ng of genomic DNA as a template in a mixture of PCR buffer, 2.5&#x000a0;mM MgCl<sub>2</sub>, 200 nM dNTPs, 0.4 pmol of each primer, and 0.75 units of h-Taq polymerase (Solgent, Daejeon, Korea; <xref ref-type="table" rid="t1">Table 1</xref>) [<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>].</p><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>Polymorphic sites of <italic>IL1A</italic>, <italic>IL1B,</italic> and <italic>IL1RN</italic>.</title></caption><table frame="hsides" rules="groups"><col width="54" span="1"/><col width="69" span="1"/><col width="84" span="1"/><col width="61" span="1"/><col width="45" span="1"/><col width="64" span="1"/><col width="109" span="1"/><col width="89" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Nucleotide</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>SNPs</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>dbSNPs</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Amino acid</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><bold>Assay method<sup>a</sup></bold></th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1"><bold>Genotypes<sup>b</sup></bold></th></tr></thead><tbody><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><italic>IL1A</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">exon 1<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;889 C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ex1+12C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1800587">rs1800587</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: DpnII<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*c: 170bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*t: 145+25bp<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">exon 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">+4845 G&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ex5+21G&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17561">rs17561</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">A114S<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: SatI<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*G:29+123+3+84bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*T:152+3+84bp<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">intron 6<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">+376 C&#x0003e;A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">IVS6+169C&#x0003e;A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071376">rs2071376</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: BstYI<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*c:270bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*a: 198+72bp<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><italic>IL1B</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">promoter<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;511C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;511T&#x0003e;C<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: AvaI<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*t:530bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*c:190+340bp<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">promoter<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;31 T&#x0003e;C<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;31 C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Direct sequencing<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">intron 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">+5810 G&#x0003e;A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">IVS4&#x02013;64G&#x0003e;A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143633">rs1143633</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: Fnu4HI<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*g:38+271+19bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*a:309+19bp<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">exon 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">+3954C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Ex5+<sup>14</sup>C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143634">rs1143634</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">F105F<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: TaqI<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*C:116+212bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*T:328bp<hr/></td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1"><italic>IL1RN</italic><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">exon 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">+8006 C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">EX4+55C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=419598">rs419598</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">A60A<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: HpaII<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*C: 29 +98 bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*T: 127 bp<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">intron 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">+8061 C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">IVS4+21C&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=423904">rs423904</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: MwoI<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*c:179+46bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*t:225bp<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">intron 4<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">86bp VNTR<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">Agarose<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">I: 410 bp, II: 240bp, III: 500bp, IV: 325 bp, V: 595 bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">intron 5<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">+9589A&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">IVS5+59A&#x0003e;T<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=454078">rs454078</ext-link><hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: SspI<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*a:299bp<hr/></td><td valign="top" align="left" rowspan="1" colspan="1">*t:145+154bp<hr/></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">exon 7</td><td valign="top" align="left" rowspan="1" colspan="1">+11100T&#x0003e;C</td><td valign="top" align="left" rowspan="1" colspan="1">Ex7+72T&#x0003e;C</td><td valign="top" align="left" rowspan="1" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=315952">rs315952</ext-link></td><td valign="top" align="left" rowspan="1" colspan="1">S133S</td><td valign="top" align="left" rowspan="1" colspan="1">RFLP: MspA1I</td><td valign="top" align="left" rowspan="1" colspan="1">*T:330bp</td><td valign="top" align="left" rowspan="1" colspan="1">*C:132+198bp</td></tr></tbody></table><table-wrap-foot><p>Assay method<sup>a</sup>: Screening method for polymorphic site and lists of restriction enzyme; Agarose: Agarose gel electrophoresis; Genotypes<sup>b</sup>: It was indicated restricted sizes by RFLP analysis and amplified products for VNTR</p></table-wrap-foot></table-wrap><p>Biallelic polymorphisms in the <italic>IL1</italic> gene cluster were determined by PCR&#x02013;restriction fragment length polymorphism (RFLP) analysis and direct sequencing (<xref ref-type="table" rid="t1">Table 1</xref>). The <italic>IL1RN</italic> VNTR polymorphism was evaluated by identifying the number of repeats in the (86)n sequence using agarose gel electrophoresis and direct sequencing [<xref ref-type="bibr" rid="r19">19</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>].</p><p>The Hardy&#x02013;Weinberg equilibrium (HWE) was calculated using the <ext-link ext-link-type="uri" xlink:href="http://genepop.curtin.edu.au/">GenePop</ext-link> web version 4.0 program. To determine statistically significant differences in genotype and allele frequencies between the two groups, we used the &#x003c7;<sup>2</sup> test or Fisher&#x02019;s exact test for the 2&#x000d7;2 contingency table file. The descriptive statistics for observed differences in allele or genotype distribution with the corresponding p values were analyzed using the <ext-link ext-link-type="uri" xlink:href="http://members.aol.com/johnp71/ctab2x2.html">JavaStat</ext-link> web software in combination with StatXact-8 software (Cytel Inc., Cambridge, MA). The strength of the association was estimated by odds ratio of risk (OR) and 95% confidence intervals (CI). Haplotype frequencies and associations were calculated with <ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/mpg/haploview/index.php">Haploview</ext-link> (version 4.0) that uses the expectation maximization (EM) algorithm [<xref ref-type="bibr" rid="r26">26</xref>]. Haplotype distributions were evaluated by the permutation test on the basis of 10,000 replications to obtain the empirical significance [<xref ref-type="bibr" rid="r26">26</xref>]. Values of p&#x0003c;0.05 were considered statistically significant.</p></sec><sec sec-type="results"><title>Results</title><p>We analyzed 11 SNPs and one VNTR marker in the <italic>IL1</italic> gene cluster: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1800587">rs1800587</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071376">rs2071376</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17561">rs17561</ext-link> for <italic>IL1A</italic>; <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143634">rs1143634</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143633">rs1143633</ext-link> for <italic>IL1B</italic>; and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=419598">rs419598</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=423904">rs423904</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=424078">rs424078</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=315952">rs315952</ext-link>, and the (86)n VNTR marker for <italic>IL1RN</italic> (<xref ref-type="fig" rid="f1">Figure 1</xref>). The <italic>IL1A</italic>, <italic>IL1B</italic>, and <italic>IL1RN</italic> genotypic and allelic frequencies in keratoconus patients are listed in <xref ref-type="table" rid="t2">Table 2</xref> and <xref ref-type="table" rid="t3">Table 3</xref>. The genotype distributions of the variants of the 12 polymorphisms in the <italic>IL1</italic> gene cluster among the control subjects and the keratoconus patients were in Hardy&#x02013;Weinberg equilibrium.</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p><italic>IL1A</italic>, <italic>IL1B</italic>, and <italic>IL1RN</italic>, showing polymorphic nucleotide sequences. The map of the three genes, which are located on 2q14, is according to the UCSC <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">Human Genome Browser</ext-link> Mar 2006 Assembly. The direction of transcription is shown above each gene by a horizontal arrow. Exons are shown as rectangles. Vertical lines indicate polymorphic sites evaluated in this study.</p></caption><graphic xlink:href="mv-v14-2109-f1"/></fig><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Genotype frequencies of <italic>IL1A</italic> and <italic>IL1B</italic> in keratoconus patients.</title></caption><table frame="hsides" rules="groups"><col width="66" span="1"/><col width="77" span="1"/><col width="75" span="1"/><col width="79" span="1"/><col width="70" span="1"/><col width="66" span="1"/><thead><tr><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Genes</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>SNPs</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Genotypes</bold></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Frequency (%)</bold><hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>p value</bold></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>Keratoconus</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Control</bold></th></tr></thead><tbody><tr><td rowspan="9" valign="top" align="center" scope="row" colspan="1"><italic>IL1A</italic><hr/></td><td rowspan="3" valign="top" align="center" colspan="1">&#x02212;889 C&#x0003e;T (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1800587">rs1800587</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">87.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">88.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td rowspan="3" valign="top" colspan="1" align="center" scope="row">+4845 G&#x0003e;T (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17561">rs17561</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">75.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">81.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">23.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">17.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td rowspan="3" valign="top" colspan="1" align="center" scope="row">+376 C&#x0003e;A (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071376">rs2071376</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">8.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">C/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">37.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.034*<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">51.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">41.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td rowspan="12" valign="top" align="center" scope="row" colspan="1"><italic>IL1B</italic></td><td rowspan="3" valign="top" align="center" colspan="1">&#x02212;511C&#x0003e;T (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.025**<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">43.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">51.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">27.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td rowspan="3" valign="top" colspan="1" align="center" scope="row">&#x02212;31 T&#x0003e;C (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">23.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">28.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">41.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">50<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">21.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.027***<hr/></td></tr><tr><td rowspan="3" valign="top" colspan="1" align="center" scope="row">+5810G&#x0003e;A (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143633">rs1143633</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">39.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">45.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">G/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">39.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">35.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">G/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">18.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td rowspan="3" valign="top" colspan="1" align="center" scope="row">+3954C&#x0003e;T (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143634">rs1143634</ext-link>)</td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">92.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">95.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T</td><td valign="top" align="center" rowspan="1" colspan="1">1.1</td><td valign="top" align="center" rowspan="1" colspan="1">1.4</td><td valign="top" align="center" rowspan="1" colspan="1">N.S.</td></tr></tbody></table><table-wrap-foot><p>The asterisk indicates that OR=0.59 and 95% CI=0.32&#x0003c;1.11. The double asterisk indicates that OR=1.96 and 95% CI=0.96&#x0003c;3.96. The triple asterisk indicates that OR=1.92 and 95% CI=0.95&#x0003c;3.90. N.S., not significant.</p></table-wrap-foot></table-wrap><table-wrap id="t3" position="float"><label>Table 3</label><caption><title>Genotype frequencies of <italic>IL1RN</italic> in keratoconus patients.</title></caption><table frame="hsides" rules="groups"><col width="67" span="1"/><col width="77" span="1"/><col width="75" span="1"/><col width="78" span="1"/><col width="70" span="1"/><col width="66" span="1"/><thead><tr><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Gene</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>SNP</bold></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>Genotypes</bold></th><th colspan="2" valign="top" align="center" scope="colgroup" rowspan="1"><bold>Frequency (%)</bold><hr/></th><th rowspan="2" valign="top" align="center" scope="col" colspan="1"><bold>p value</bold></th></tr><tr><th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1"><bold>Keratoconus</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Control</bold></th></tr></thead><tbody><tr><td rowspan="18" valign="top" align="center" scope="row" colspan="1"><italic>IL1RN</italic></td><td rowspan="3" valign="top" align="center" colspan="1">+8006 C&#x0003e;T (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=419598">rs419598</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">86.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">87.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td rowspan="3" valign="top" colspan="1" align="center" scope="row">+8061 C&#x0003e;T (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=423904">rs423904</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">86.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">87.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">12.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td rowspan="3" valign="top" colspan="1" align="center" scope="row">+9589A&#x0003e;T (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=454078">rs454078</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">86.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">85.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">11.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">14.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td rowspan="3" valign="top" colspan="1" align="center" scope="row">+11100T&#x0003e;C (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=315952">rs315952</ext-link>)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">46.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">17.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td rowspan="6" valign="top" colspan="1" align="center" scope="row">VNTR</td><td valign="top" align="center" rowspan="1" colspan="1">1/1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">81.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">83.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">1/2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">13.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">2/2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">3/1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">3/3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.0<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">N.S.<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">4/1</td><td valign="top" align="center" rowspan="1" colspan="1">0.7</td><td valign="top" align="center" rowspan="1" colspan="1">2.7</td><td valign="top" align="center" rowspan="1" colspan="1">N.S.</td></tr></tbody></table><table-wrap-foot><p>N.S., not significant.</p></table-wrap-foot></table-wrap><p>Of the four SNPs in <italic>IL1B</italic>, the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link> (&#x02212;31T&#x0003e;C) and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link> (&#x02212;511C&#x0003e;T) positions in the promoter region of <italic>IL1B</italic> were significantly different between the patient and control groups. For <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link> (&#x02212;511 T&#x0003e;C), the frequency of the *C/*C genotype was higher in the patients (34.8%) than in control subjects (21.4%; p=0.025, OR=1.96, 95% CI 0.96&#x0003c;3.96). The *C allele frequency at <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link> was also higher in the patients (56.5%) than in the control subjects (47.1%; p=0.022, OR=1.46, 95% CI 0.94&#x0003c;2.27). The distribution of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link> (&#x02212;31C&#x0003e;T) *T/*T, *T/*C, and *C/*C genotype frequencies were 34.4, 41.9, and 23.7, respectively, in keratoconus patients and 21.4, 50.0, and 28.6, respectively, in control subjects. The *T/*T genotype frequency had a higher risk of occurring in keratoconus patients than in control subjects (p=0.027, OR=1.92, 95% CI 0.95&#x0003c;3.90). The allele frequency of *T was 55.4% in keratoconus patients and 46.4% in control subjects (p=0.025, OR=1.43, 95% CI 0.92&#x0003c;2.22).</p><p>Of the three SNPs in <italic>IL1A</italic>, the *C/*A genotype for <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071376">rs2071376</ext-link> in intron 6 was significantly different between keratoconus patients and control subjects (p=0.034, OR=0.59, 95% CI 0.32&#x0003c;1.11), but the allele frequencies were not significantly different between the groups. Other SNPs and the VNTR showed no significant genotype or allele frequency differences between keratoconus patients and control subjects.</p><p>In the haplotype analysis, we identified three haplotype block sets, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071376">rs2071376</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17561">rs17561</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1800587">rs1800587</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143634">rs1143634</ext-link> for Block A, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link> for Block B, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=419598">rs419598</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=423904">rs423904</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=454078">rs454078</ext-link> for Block C (<xref ref-type="fig" rid="f2">Figure 2</xref>). The T-C haplotype in Block B was more prevalent in keratoconus patients than in control subjects and was associated with a higher risk of developing keratoconus (p=0.034, OR=1.58, 95% CI 1.018&#x0003c;2.448). In contrast, the T-T haplotype in Block B was less frequent in the keratoconus group compared with the control group (p=0.009; <xref ref-type="table" rid="t4">Table 4</xref>).</p><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>Haplotype structure of select SNPs in <italic>IL1A</italic>, <italic>IL1B</italic>, and <italic>IL1RN</italic>. We estimated the pairwise linkage disequilibrium (LD) by calculating pairwise D' and r<sup>2</sup> based on marker-marker D'&#x0003e;0.70 and r<sup>2</sup>&#x0003e;0.80. The images were generated with the <ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/mpg/haploview/index.php">Haploview</ext-link> software pack.</p></caption><graphic xlink:href="mv-v14-2109-f2"/></fig><table-wrap id="t4" position="float"><label>Table 4</label><caption><title>Haplotype analysis of the interleukin 1 genes in keratoconus patients.</title></caption><table frame="hsides" rules="groups"><col width="84" span="1"/><col width="89" span="1"/><col width="93" span="1"/><col width="83" span="1"/><col width="84" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Block</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Haplotype</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Case:Control frequency</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>&#x003c7;<sup>2</sup></bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>p value</bold></th></tr></thead><tbody><tr><td rowspan="6" valign="top" align="center" scope="row" colspan="1">Block 1<hr/></td><td colspan="4" valign="top" align="center" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071376">rs2071376</ext-link>&#x02028;-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=17561">rs17561</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1800587">rs1800587</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143634">rs1143634</ext-link><hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">CGCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.656:0.634<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.168<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.682<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">AGCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.217:0.266<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.031<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.309<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">ATTT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.042:0.029<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.421<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.516<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">CTCC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.041:0.030<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.281<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.596<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">ATTC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.032:0.036<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.043<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.836<hr/></td></tr><tr><td rowspan="5" valign="top" align="center" scope="row" colspan="1">Block 2<hr/></td><td colspan="4" valign="top" align="center" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link>&#x02028;-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link><hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">TC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.556:0.442<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.161<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.034*<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">CT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.394:0.492<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3.176<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.075<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">CC<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.049:0.029<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.813<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.367<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">TT<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.001:0.037<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">6.168<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.009**<hr/></td></tr><tr><td rowspan="3" valign="top" align="center" scope="row" colspan="1">Block 3</td><td colspan="4" valign="top" align="center" rowspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=419598">rs419598</ext-link>&#x02028;-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=423904">rs423904</ext-link>-<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=454078">rs454078</ext-link><hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">TCA<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.916:0.929<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.181<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.67<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">CTT</td><td valign="top" align="center" rowspan="1" colspan="1">0.074:0.064</td><td valign="top" align="center" rowspan="1" colspan="1">0.11</td><td valign="top" align="center" rowspan="1" colspan="1">0.74</td></tr></tbody></table><table-wrap-foot><p>The asterisk indicates that OR=1.58 and 95% CI=1.018&#x0003c;2.448, and the double asterisk indicates that OR=0.04 and 95% CI=0.003&#x0003c;0.667.</p></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>Keratoconus is an abnormality of the interactive epithelial-stromal system that causes a shift in the delicate balance between keratocyte proliferation and apoptosis [<xref ref-type="bibr" rid="r12">12</xref>]. Using the TUNEL assay, Kim et al. [<xref ref-type="bibr" rid="r12">12</xref>] confirmed the presence of keratocyte apoptosis in keratoconus corneas and the absence of keratocyte apoptosis in normal corneas. Keratocyte apoptosis may be triggered by increased basal IL1 release [<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r14">14</xref>,<xref ref-type="bibr" rid="r27">27</xref>]. Previous studies indicated that corneal fibroblasts from keratoconus patients express about three times more <italic>IL1A</italic> mRNA than those from a normal cornea [<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r28">28</xref>]. Zhou et al. [<xref ref-type="bibr" rid="r29">29</xref>] reported that the IL1 protein level was higher in the epithelium and endothelium of the keratoconus corneas than in normal corneas. In addition, IL1 upregulates keratocyte expression of collagenases, metalloproteinases, and other enzymes [<xref ref-type="bibr" rid="r30">30</xref>,<xref ref-type="bibr" rid="r31">31</xref>]. These enzymes have important roles in the remodeling of collagen during corneal wound healing. For example, persistent rubbing of the eye is likely to produce corneal epithelial trauma and increase the release of IL1 [<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r32">32</xref>,<xref ref-type="bibr" rid="r33">33</xref>]. This would provide a unifying explanation for the association between keratoconus and factors associated with mechanical corneal epithelial cell injury such as poorly fitted rigid contact lenses, excessive eye rubbing, and allergic ocular surface disease [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r34">34</xref>]. Therefore, it has been suggested that interleukins are central modulators of the response to corneal injury.</p><p>The IL1 superfamily includes three secreted glycoproteins, IL1&#x003b1;, IL1&#x003b2;, and IL1Ra. Two of these, IL1&#x003b1; and IL1&#x003b2;, are biologically active while the third member, IL1Ra, is a receptor antagonist that modulates the effects of IL1&#x003b1; and IL1&#x003b2; [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>]. IL1&#x003b1; and IL1&#x003b2; proteins are synthesized by a variety of cell types including activated macrophages, stimulated B lymphocytes, fibroblasts, and endothelial cells. They are powerful mediators of inflammation and the immune response. <italic>IL1A</italic>, <italic>IL1B</italic>, and <italic>IL1RN</italic> map to human chromosome 2q14. Gene variations that alter gene function are more likely to influence phenotypic characteristics such as risk of disease [<xref ref-type="bibr" rid="r18">18</xref>]. An in vivo study showed that the <italic>IL1A</italic>-889 *T allele was associated with increased IL1&#x003b1; and IL1&#x003b2; protein levels. Furthermore, ex vivo analysis of lipopolysaccharide (LPS)-stimulated peripheral blood mononuclear cells indicated that production of IL1&#x003b1; from <italic>IL1A</italic> with the <italic>IL1A</italic>-889*T allele increased [<xref ref-type="bibr" rid="r35">35</xref>,<xref ref-type="bibr" rid="r36">36</xref>]. The two promoter variants of <italic>IL1B</italic>, &#x02212;511C&#x0003e;T and &#x02212;31T&#x0003e;C SNPs, have been repeatedly associated with multiple clinical conditions [<xref ref-type="bibr" rid="r37">37</xref>,<xref ref-type="bibr" rid="r38">38</xref>] such as cardiovascular disease [<xref ref-type="bibr" rid="r39">39</xref>] and gastric cancer [<xref ref-type="bibr" rid="r40">40</xref>] as well as with clinically observed differences in the levels of IL1&#x003b2; protein in vivo [<xref ref-type="bibr" rid="r39">39</xref>,<xref ref-type="bibr" rid="r41">41</xref>]. The *T allele at &#x02212;31 in the TATA box of the <italic>IL1B</italic> promoter region is suspected to enhance gene expression and induction of IL1&#x003b2; [<xref ref-type="bibr" rid="r42">42</xref>]. The -31 *C allele was associated with increased IL1&#x003b2; levels and decreased IL1&#x003b1; levels [<xref ref-type="bibr" rid="r43">43</xref>]. It has been reported that the T and C variants at the <italic>IL1B</italic> &#x02212;31 position regulate gene expression and differential binding of proteins. A specific haplotype, which is composed of the T allele at &#x02212;511 and the C allele at &#x02212;31, was significantly associated with a twofold to threefold increase in LPS-induced IL1&#x003b2; protein secretion [<xref ref-type="bibr" rid="r21">21</xref>]. There was also nearly a complete linkage disequilibrium between &#x02212;511C&#x0003e;T and &#x02212;31T&#x0003e;C in <italic>IL1B</italic> based on a <italic>cis</italic> interaction [<xref ref-type="bibr" rid="r40">40</xref>,<xref ref-type="bibr" rid="r42">42</xref>].</p><p>Some studies have suggested that the allelic polymorphism located within intron 2 of <italic>IL1RN</italic> play a role in differential modulating IL1 activity. The <italic>IL1RA</italic>*2 is associated with increased IL1Ra protein production in vitro [<xref ref-type="bibr" rid="r44">44</xref>]. The *C allele of +8006 C/T in exon 2 of <italic>IL1RN</italic> is associated with the VNTR allele 2 and is associated with lower expression of IL1Ra [<xref ref-type="bibr" rid="r45">45</xref>,<xref ref-type="bibr" rid="r46">46</xref>]. The <italic>IL1B</italic>-511C, <italic>IL1B</italic>-31T, and <italic>ILRN</italic>+8006T haplotype (C-T-T), which has been associated with lower levels of IL1&#x003b2; expression [<xref ref-type="bibr" rid="r21">21</xref>,<xref ref-type="bibr" rid="r38">38</xref>], was present in the extended protective haplotype. This extended protective haplotype contains the <italic>IL1RN</italic>+8006T allele, which is associated with elevated IL1Ra expression [<xref ref-type="bibr" rid="r45">45</xref>]. Therefore, these studies suggest that <italic>IL1</italic> gene cluster polymorphisms may affect susceptibility to the development of specific diseases and that linkage disequilibrium of functional polymorphisms may indicate increased risk of developing these diseases.</p><p>In the present study, we have reported the results of a mutation screening of interleukin 1 genes in unrelated Korean patients with keratoconus. In the screen of four SNPs of <italic>IL1B</italic>, the genotypes of &#x02013;511 *C/*C and &#x02013;31 *T/*T of <italic>IL1B</italic> SNPs were associated with a 1.96 fold and 1.92 fold greater risk of developing keratoconus, respectively, (p=0.025 and p=0.027, respectively), showing a strong statistical association with keratoconus in unrelated patients. Two <italic>IL1B</italic> SNPs, &#x02212;31C/T and &#x02212;511T/C, have been implicated as potential risk factors for keratoconus among unrelated patients. Of the three SNPs in <italic>IL1A</italic>, the *C/*A genotype of <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2071376">rs2071376</ext-link> in intron 6 differed significantly between the keratoconus patients and control subjects (p=0.034, OR=0.59, 95% CI 0.32&#x0003c;1.11), but the allele frequencies were not significantly different between the groups.</p><p>The T-C haplotype of <italic>IL1B</italic> &#x02212;31 and &#x02013;511 was more prevalent in keratoconus patients than in control subjects and carried a higher risk of keratoconus (p=0.034, OR=1.58, 95% CI 1.018&#x0003c;2.448). The T-T haplotype of <italic>IL1B</italic> &#x02212;31 and &#x02212;511 was less frequent in keratoconus patients than in the control individuals (p=0.009), which was associated with protection.</p><p>Our study is the first to report on <italic>IL1</italic> gene cluster polymorphisms in Korean keratoconus patients. We detected two disease-associated SNPs, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1143627">rs1143627</ext-link> (&#x02212;31T&#x0003e;C) and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=16944">rs16944</ext-link> (&#x02212;511C&#x0003e;T), in <italic>IL1B</italic> and a disease- associated haplotype, the <italic>IL1B</italic>-31T/-511C haplotype, which is associated with regulation of IL1&#x003b1; and IL1&#x003b2; production. It proves that IL1 may have important roles as central modulators of keratoconus development. In conclusion, the present study suggests that two SNPs in <italic>IL1B</italic> predict keratoconus predisposition in unrelated Korean patients, although further research is necessary to elucidate the relationship between the expression levels of IL1&#x003b1;, IL1&#x003b2;, and IL1Ra and SNPs of <italic>IL1B</italic> in keratoconus patients.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank the Korea Eye Tissue and Gene Bank at the Catholic University of Korea and the staff of the Department of Ophthalmology at St. Mary&#x02019;s Hospital. The authors thank M. Hwang for useful discussion.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krachmer</surname><given-names>JH</given-names></name><name><surname>Feder</surname><given-names>RS</given-names></name><name><surname>Belin</surname><given-names>MW</given-names></name></person-group><article-title>Keratoconus and related noninflammatory corneal thinning disorders.</article-title><source>Surv Ophthalmol</source><year>1984</year><volume>28</volume><fpage>293</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">6230745</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rabinowitz</surname><given-names>YS</given-names></name></person-group><article-title>Keratoconus.</article-title><source>Surv Ophthalmol</source><year>1998</year><volume>42</volume><fpage>297</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">9493273</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bron</surname><given-names>AJ</given-names></name></person-group><article-title>Keratoconus.</article-title><source>Cornea</source><year>1988</year><volume>7</volume><fpage>163</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">3048880</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cristina Kenney</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>DJ</given-names></name></person-group><article-title>The cascade hypothesis of keratoconus.</article-title><source>Cont Lens Anterior Eye</source><year>2003</year><volume>26</volume><fpage>139</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">16303509</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bawazeer</surname><given-names>AM</given-names></name><name><surname>Hodge</surname><given-names>WG</given-names></name><name><surname>Lorimer</surname><given-names>B</given-names></name></person-group><article-title>Atopy and keratoconus: a multivariate analysis.</article-title><source>Br J Ophthalmol</source><year>2000</year><volume>84</volume><fpage>834</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10906086</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macsai</surname><given-names>MS</given-names></name><name><surname>Varley</surname><given-names>GA</given-names></name><name><surname>Krachmer</surname><given-names>JH</given-names></name></person-group><article-title>Development of keratoconus after contact lens wear.</article-title><source>Arch Ophthalmol</source><year>1990</year><volume>108</volume><fpage>534</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2322155</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>D</given-names></name><name><surname>Chwa</surname><given-names>MM</given-names></name><name><surname>Opbroek</surname><given-names>A</given-names></name><name><surname>Kenney</surname><given-names>MC</given-names></name></person-group><article-title>Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors.</article-title><source>Curr Eye Res</source><year>1993</year><volume>12</volume><fpage>571</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">8359032</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawaguchi</surname><given-names>S</given-names></name><name><surname>Twining</surname><given-names>SS</given-names></name><name><surname>Yue</surname><given-names>BY</given-names></name><name><surname>Wilson</surname><given-names>PM</given-names></name><name><surname>Sugar</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>SK</given-names></name></person-group><article-title>Alpha-1 proteinase inhibitor levels in keratoconus.</article-title><source>Exp Eye Res</source><year>1990</year><volume>50</volume><fpage>549</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">2197100</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Opbroek</surname><given-names>A</given-names></name><name><surname>Kenney</surname><given-names>MC</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name></person-group><article-title>Characterization of a human corneal metalloproteinase inhibitor (TIMP-1).</article-title><source>Curr Eye Res</source><year>1993</year><volume>12</volume><fpage>877</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">7507419</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Sawaguchi</surname><given-names>S</given-names></name><name><surname>Twining</surname><given-names>SS</given-names></name><name><surname>Sugar</surname><given-names>J</given-names></name><name><surname>Feder</surname><given-names>RS</given-names></name><name><surname>Yue</surname><given-names>BY</given-names></name></person-group><article-title>Expression of degradative enzymes and protease inhibitors in corneas with keratoconus.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1998</year><volume>39</volume><fpage>1117</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">9620070</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buddi</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Atilano</surname><given-names>SR</given-names></name><name><surname>Zorapapel</surname><given-names>NC</given-names></name><name><surname>Kenney</surname><given-names>MC</given-names></name><name><surname>Brown</surname><given-names>DJ</given-names></name></person-group><article-title>Evidence of oxidative stress in human corneal diseases.</article-title><source>J Histochem Cytochem</source><year>2002</year><volume>50</volume><fpage>341</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">11850437</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>WJ</given-names></name><name><surname>Rabinowitz</surname><given-names>YS</given-names></name><name><surname>Meisler</surname><given-names>DM</given-names></name><name><surname>Wilson</surname><given-names>SE</given-names></name></person-group><article-title>Keratoocyte apoptosis associated with keratoconus.</article-title><source>Exp Eye Res</source><year>1999</year><volume>69</volume><fpage>475</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">10548467</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SE</given-names></name><name><surname>Kim</surname><given-names>WJ</given-names></name></person-group><article-title>Keratocyte apoptosis: implications on corneal wound healing, tissue organization, and disease.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1998</year><volume>39</volume><fpage>220</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9477978</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SE</given-names></name><name><surname>He</surname><given-names>YG</given-names></name><name><surname>Weng</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>McDowall</surname><given-names>AW</given-names></name><name><surname>Vital</surname><given-names>M</given-names></name><name><surname>Chwang</surname><given-names>EL</given-names></name></person-group><article-title>Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-1 system in the modulation of corneal tissue organization and wound healing.</article-title><source>Exp Eye Res</source><year>1996</year><volume>62</volume><fpage>325</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8795451</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fabre</surname><given-names>EJ</given-names></name><name><surname>Bureau</surname><given-names>J</given-names></name><name><surname>Pouliquen</surname><given-names>Y</given-names></name><name><surname>Lorans</surname><given-names>G</given-names></name></person-group><article-title>Binding sites for human interleukin 1 alpha, gamma interferon and tumor necrosis factor on cultured fibroblasts of normal cornea and keratoconus.</article-title><source>Curr Eye Res</source><year>1991</year><volume>10</volume><fpage>585</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">1914496</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaldawy</surname><given-names>RM</given-names></name><name><surname>Wagner</surname><given-names>J</given-names></name><name><surname>Ching</surname><given-names>S</given-names></name><name><surname>Seigel</surname><given-names>GM</given-names></name></person-group><article-title>Evidence of apoptotic cell death in keratoconus.</article-title><source>Cornea</source><year>2002</year><volume>21</volume><fpage>206</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11862097</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nicklin</surname><given-names>MJ</given-names></name><name><surname>Weith</surname><given-names>A</given-names></name><name><surname>Duff</surname><given-names>GW</given-names></name></person-group><article-title>A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes.</article-title><source>Genomics</source><year>1994</year><volume>19</volume><fpage>382</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">8188271</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roux-Lombard</surname><given-names>P</given-names></name></person-group><article-title>The interleukin 1 family.</article-title><source>Eur Cytokine Netw</source><year>1998</year><volume>9</volume><fpage>565</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">9889400</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Steinkasserer</surname><given-names>A</given-names></name><name><surname>Spurr</surname><given-names>NK</given-names></name><name><surname>Cox</surname><given-names>S</given-names></name><name><surname>Jeggo</surname><given-names>P</given-names></name><name><surname>Sim</surname><given-names>RB</given-names></name></person-group><article-title>The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci.</article-title><source>Genomics</source><year>1992</year><volume>13</volume><fpage>654</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">1386337</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Endres</surname><given-names>S</given-names></name><name><surname>Cannon</surname><given-names>JG</given-names></name><name><surname>Ghorbani</surname><given-names>R</given-names></name><name><surname>Dempsey</surname><given-names>RA</given-names></name><name><surname>Sisson</surname><given-names>SD</given-names></name><name><surname>Lonnemann</surname><given-names>G</given-names></name><name><surname>Van der Meer</surname><given-names>JW</given-names></name><name><surname>Wolf</surname><given-names>SM</given-names></name><name><surname>Dinarello</surname><given-names>CA</given-names></name></person-group><article-title>In vitro production of IL-1beta, IL-1 alpha, TNF and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation.</article-title><source>Eur J Immunol</source><year>1989</year><volume>19</volume><fpage>2327</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">2514105</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>SK</given-names></name><name><surname>Perregaux</surname><given-names>DG</given-names></name><name><surname>Gabel</surname><given-names>CA</given-names></name><name><surname>Woodworth</surname><given-names>T</given-names></name><name><surname>Durham</surname><given-names>LK</given-names></name><name><surname>Huizinga</surname><given-names>TW</given-names></name><name><surname>Breedveld</surname><given-names>FC</given-names></name><name><surname>Seymour</surname><given-names>AB</given-names></name></person-group><article-title>Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein.</article-title><source>Arthritis Rheum</source><year>2004</year><volume>50</volume><fpage>1976</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">15188375</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kilpinen</surname><given-names>S</given-names></name><name><surname>Huhtala</surname><given-names>H</given-names></name><name><surname>Hurme</surname><given-names>M</given-names></name></person-group><article-title>The combination of the interleukin-1alpha (IL-1alpha-889) genotype and the interleukin-10 (IL-10 ATA) haplotype is associated with increased interleukin-10 (IL-10) plasma levels in healthy individuals.</article-title><source>Eur Cytokine Netw</source><year>2002</year><volume>13</volume><fpage>66</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">11956022</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>TT</given-names></name><name><surname>Szczotka-Flynn</surname><given-names>L</given-names></name><name><surname>Barr</surname><given-names>JT</given-names></name><name><surname>Anderson</surname><given-names>RJ</given-names></name><name><surname>Slaughter</surname><given-names>ME</given-names></name><name><surname>Lass</surname><given-names>JH</given-names></name><name><surname>Iyengar</surname><given-names>SK</given-names></name></person-group><article-title>CLEK Study Group. A new method for grading the severity of keratoconus: the Keratoconus Severity Score (KSS).</article-title><source>Cornea</source><year>2006</year><volume>25</volume><fpage>794</fpage><lpage>800</lpage><pub-id pub-id-type="pmid">17068456</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Timms</surname><given-names>AE</given-names></name><name><surname>Crane</surname><given-names>AM</given-names></name><name><surname>Sims</surname><given-names>AM</given-names></name><name><surname>Cordell</surname><given-names>HJ</given-names></name><name><surname>Bradbury</surname><given-names>LA</given-names></name><name><surname>Abbott</surname><given-names>A</given-names></name><name><surname>Coyne</surname><given-names>MR</given-names></name><name><surname>Beynon</surname><given-names>O</given-names></name><name><surname>Herzberg</surname><given-names>I</given-names></name><name><surname>Duff</surname><given-names>GW</given-names></name><name><surname>Calin</surname><given-names>A</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name><name><surname>Wordsworth</surname><given-names>BP</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name></person-group><article-title>The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis.</article-title><source>Am J Hum Genet</source><year>2004</year><volume>75</volume><fpage>587</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">15309690</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cantagrel</surname><given-names>A</given-names></name><name><surname>Navaux</surname><given-names>F</given-names></name><name><surname>Loubet-Lescouli&#x000e9;</surname><given-names>P</given-names></name><name><surname>Nourhashemi</surname><given-names>F</given-names></name><name><surname>Enault</surname><given-names>G</given-names></name><name><surname>Abbal</surname><given-names>M</given-names></name><name><surname>Constantin</surname><given-names>A</given-names></name><name><surname>Laroche</surname><given-names>M</given-names></name><name><surname>Mazi&#x000e8;res</surname><given-names>B</given-names></name></person-group><article-title>Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis.</article-title><source>Arthritis Rheum</source><year>1999</year><volume>42</volume><fpage>1093</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">10366101</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Fry</surname><given-names>B</given-names></name><name><surname>Maller</surname><given-names>J</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><article-title>Haploview: analysis and visualization of LD and haplotype maps.</article-title><source>Bioinformatics</source><year>2005</year><volume>21</volume><fpage>263</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15297300</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helena</surname><given-names>MC</given-names></name><name><surname>Baeveldt</surname><given-names>F</given-names></name><name><surname>Kim</surname><given-names>WJ</given-names></name><name><surname>Wilson</surname><given-names>SE</given-names></name></person-group><article-title>Keratocyte apoptosis following corneal surgery.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1998</year><volume>39</volume><fpage>276</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">9477983</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barbaro</surname><given-names>V</given-names></name><name><surname>Di Iorio</surname><given-names>E</given-names></name><name><surname>Ferrari</surname><given-names>S</given-names></name><name><surname>Bisceglia</surname><given-names>L</given-names></name><name><surname>Ruzza</surname><given-names>A</given-names></name><name><surname>De Luca</surname><given-names>M</given-names></name><name><surname>Pellegrini</surname><given-names>G</given-names></name></person-group><article-title>Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>5243</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">17122109</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zabaleta</surname><given-names>J</given-names></name><name><surname>Camargo</surname><given-names>MC</given-names></name><name><surname>Piazuelo</surname><given-names>MB</given-names></name><name><surname>Fontham</surname><given-names>E</given-names></name><name><surname>Schneider</surname><given-names>BG</given-names></name><name><surname>Sicinschi</surname><given-names>LA</given-names></name><name><surname>Ferrante</surname><given-names>W</given-names></name><name><surname>Balart</surname><given-names>L</given-names></name><name><surname>Correa</surname><given-names>P</given-names></name><name><surname>Ochoa</surname><given-names>AC</given-names></name></person-group><article-title>Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians.</article-title><source>Am J Gastroenterol</source><year>2006</year><volume>101</volume><fpage>163</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">16405550</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>West-Mays</surname><given-names>JA</given-names></name><name><surname>Sadow</surname><given-names>PM</given-names></name><name><surname>Tobin</surname><given-names>TW</given-names></name><name><surname>Strissel</surname><given-names>KJ</given-names></name><name><surname>Cintron</surname><given-names>C</given-names></name><name><surname>Fini</surname><given-names>ME</given-names></name></person-group><article-title>Repair phenotype in corneal fibroblasts is controlled by an interleukin-1 alpha autocrine feedback loop.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1997</year><volume>38</volume><fpage>1367</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">9191600</pub-id></citation></ref><ref id="r31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strissel</surname><given-names>KJ</given-names></name><name><surname>Rinehart</surname><given-names>WB</given-names></name><name><surname>Fini</surname><given-names>ME</given-names></name></person-group><article-title>Regulation of paracrine cytokine balance controlling collagenase synthesis by corneal cells.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1997</year><volume>38</volume><fpage>546</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">9040490</pub-id></citation></ref><ref id="r32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SE</given-names></name><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Mohan</surname><given-names>RR</given-names></name></person-group><article-title>Stromal-epithelial interactions in the cornea.</article-title><source>Prog Retin Eye Res</source><year>1999</year><volume>18</volume><fpage>293</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">10192515</pub-id></citation></ref><ref id="r33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SE</given-names></name><name><surname>Mohan</surname><given-names>RR</given-names></name><name><surname>Mohan</surname><given-names>RR</given-names></name><name><surname>Ambr&#x000f3;sio</surname><given-names>R</given-names><suffix>Jr</suffix></name><name><surname>Hong</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name></person-group><article-title>The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells.</article-title><source>Prog Retin Eye Res</source><year>2001</year><volume>20</volume><fpage>625</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">11470453</pub-id></citation></ref><ref id="r34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chwa</surname><given-names>M</given-names></name><name><surname>Atilano</surname><given-names>SR</given-names></name><name><surname>Reddy</surname><given-names>V</given-names></name><name><surname>Jordan</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Kenney</surname><given-names>MC</given-names></name></person-group><article-title>Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts.</article-title><source>Invest Ophthalmol Vis Sci</source><year>2006</year><volume>47</volume><fpage>1902</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">16638997</pub-id></citation></ref><ref id="r35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dominici</surname><given-names>R</given-names></name><name><surname>Cattaneo</surname><given-names>M</given-names></name><name><surname>Malferrari</surname><given-names>G</given-names></name><name><surname>Archi</surname><given-names>D</given-names></name><name><surname>Mariani</surname><given-names>C</given-names></name><name><surname>Grimaldi</surname><given-names>LM</given-names></name><name><surname>Biunno</surname><given-names>I</given-names></name></person-group><article-title>Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha.</article-title><source>Immunogenetics</source><year>2002</year><volume>54</volume><fpage>82</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12037600</pub-id></citation></ref><ref id="r36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shirodaria</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>McKay</surname><given-names>IJ</given-names></name><name><surname>Kennett</surname><given-names>CN</given-names></name><name><surname>Hughes</surname><given-names>FJ</given-names></name></person-group><article-title>Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease.</article-title><source>J Dent Res</source><year>2000</year><volume>79</volume><fpage>1864</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11145356</pub-id></citation></ref><ref id="r37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Momiyama</surname><given-names>Y</given-names></name><name><surname>Hirano</surname><given-names>R</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Ohsuzu</surname><given-names>F</given-names></name></person-group><article-title>Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumonia infection.</article-title><source>J Am Coll Cardiol</source><year>2001</year><volume>38</volume><fpage>712</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11527622</pub-id></citation></ref><ref id="r38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Camargo</surname><given-names>JF</given-names></name><name><surname>Correa</surname><given-names>PA</given-names></name><name><surname>Castiblanco</surname><given-names>J</given-names></name><name><surname>Anaya</surname><given-names>JM</given-names></name></person-group><article-title>Interleukin-1beta polymorphisms in Colombian patients with autoimmune rheumatic diseases.</article-title><source>Genes Immun</source><year>2004</year><volume>5</volume><fpage>609</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">15470475</pub-id></citation></ref><ref id="r39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iacoviello</surname><given-names>L</given-names></name><name><surname>Di Castelnuovo</surname><given-names>A</given-names></name><name><surname>Gattone</surname><given-names>M</given-names></name><name><surname>Pezzini</surname><given-names>A</given-names></name><name><surname>Assanelli</surname><given-names>D</given-names></name><name><surname>Lorenzet</surname><given-names>R</given-names></name><name><surname>Del Zotto</surname><given-names>E</given-names></name><name><surname>Colombo</surname><given-names>M</given-names></name><name><surname>Napoleone</surname><given-names>E</given-names></name><name><surname>Amore</surname><given-names>C</given-names></name><name><surname>D'Orazio</surname><given-names>A</given-names></name><name><surname>Padovani</surname><given-names>A</given-names></name><name><surname>de Gaetano</surname><given-names>G</given-names></name><name><surname>Giannuzzi</surname><given-names>P</given-names></name><name><surname>Donati</surname><given-names>MB</given-names></name></person-group><article-title>IGIGI Investigators. Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro.</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2005</year><volume>25</volume><fpage>222</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15539626</pub-id></citation></ref><ref id="r40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>YW</given-names></name><name><surname>Jang</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>NH</given-names></name><name><surname>Lee</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Jung</surname><given-names>WW</given-names></name><name><surname>Dong</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>BH</given-names></name><name><surname>Lee</surname><given-names>JI</given-names></name><name><surname>Chang</surname><given-names>R</given-names></name></person-group><article-title>Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer.</article-title><source>Int J Cancer</source><year>2005</year><volume>114</volume><fpage>465</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15551344</pub-id></citation></ref><ref id="r41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hulkkonen</surname><given-names>J</given-names></name><name><surname>Laippala</surname><given-names>P</given-names></name><name><surname>Hurme</surname><given-names>M</given-names></name></person-group><article-title>A rare allele combination of the interleukin-1 gene complex is associated with high interleukin-1 beta plasma levels in healthy individuals.</article-title><source>Eur Cytokine Netw</source><year>2000</year><volume>11</volume><fpage>251</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">10903804</pub-id></citation></ref><ref id="r42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Wilkins</surname><given-names>LM</given-names></name><name><surname>Aziz</surname><given-names>N</given-names></name><name><surname>Cannings</surname><given-names>C</given-names></name><name><surname>Wyllie</surname><given-names>DH</given-names></name><name><surname>Bingle</surname><given-names>C</given-names></name><name><surname>Rogus</surname><given-names>J</given-names></name><name><surname>Beck</surname><given-names>JD</given-names></name><name><surname>Offenbacher</surname><given-names>S</given-names></name><name><surname>Cork</surname><given-names>MJ</given-names></name><name><surname>Rafie-Kolpin</surname><given-names>M</given-names></name><name><surname>Hsieh</surname><given-names>CM</given-names></name><name><surname>Kornman</surname><given-names>KS</given-names></name><name><surname>Duff</surname><given-names>GW</given-names></name></person-group><article-title>Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context.</article-title><source>Hum Mol Genet</source><year>2006</year><volume>15</volume><fpage>519</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">16399797</pub-id></citation></ref><ref id="r43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Jongh</surname><given-names>CM</given-names></name><name><surname>Khrenova</surname><given-names>L</given-names></name><name><surname>Kezic</surname><given-names>S</given-names></name><name><surname>Rustemeyer</surname><given-names>T</given-names></name><name><surname>Verberk</surname><given-names>MM</given-names></name><name><surname>John</surname><given-names>SM</given-names></name></person-group><article-title>Polymorphisms in the interleukin-1 gene influence the stratum corneum interleukin-1 alpha concentration in uninvolved skin of patients with chronic irritant contact dermatitis.</article-title><source>Contact Dermatitis</source><year>2008</year><volume>58</volume><fpage>263</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18416755</pub-id></citation></ref><ref id="r44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Danis</surname><given-names>VA</given-names></name><name><surname>Millington</surname><given-names>M</given-names></name><name><surname>Hyland</surname><given-names>VJ</given-names></name><name><surname>Grennan</surname><given-names>D</given-names></name></person-group><article-title>Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism.</article-title><source>Clin Exp Immunol</source><year>1995</year><volume>99</volume><fpage>303</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">7851026</pub-id></citation></ref><ref id="r45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>MJ</given-names></name><name><surname>di Giovine</surname><given-names>FS</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Mee</surname><given-names>J</given-names></name><name><surname>Camp</surname><given-names>NJ</given-names></name><name><surname>Lobo</surname><given-names>AJ</given-names></name><name><surname>Duff</surname><given-names>GW</given-names></name></person-group><article-title>Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians.</article-title><source>Gut</source><year>2001</year><volume>48</volume><fpage>461</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11247888</pub-id></citation></ref><ref id="r46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arnalich</surname><given-names>F</given-names></name><name><surname>L&#x000f3;pez-Maderuelo</surname><given-names>D</given-names></name><name><surname>Codoceo</surname><given-names>R</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>J</given-names></name><name><surname>Solis-Garrido</surname><given-names>LM</given-names></name><name><surname>Capiscol</surname><given-names>C</given-names></name><name><surname>Fernandez-Capit&#x000e1;n</surname><given-names>C</given-names></name><name><surname>Madero</surname><given-names>R</given-names></name><name><surname>Montiel</surname><given-names>C</given-names></name></person-group><article-title>Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis.</article-title><source>Clin Exp Immunol</source><year>2002</year><volume>127</volume><fpage>331</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11876758</pub-id></citation></ref></ref-list></back></article> 